Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
BOSTON, 20 nov. 2025 (GLOBE NEWSWIRE) -- Anaqua, le principal fournisseur de solutions et de services technologiques pour la gestion de l'innovation et de la propriété intellectuelle (PI), a annoncé...
-
BOSTON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Anaqua, the leading provider of innovation and intellectual property (IP) management technology solutions and services, today announced the upcoming launch...
-
San Mateo, CA, Nov. 20, 2025 (GLOBE NEWSWIRE) -- BriteCore, the leading cloud-native core insurance platform trusted by P&C insurers and MGAs across North America, is proud to announce its...
-
EDAP Receives FDA 510(k) Clearance for Latest Evolution of Focal One Robotic HIFU AUSTIN, Texas, November 20, 2025 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies,...
-
MUNICH, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Anaqua, the leading provider of innovation and intellectual property (IP) management technology solutions and services, today announced the upcoming launch...
-
PRESS RELEASE Wolters Kluwer completes acquisition of Libra Technology GmbH Alphen aan den Rijn — November 19, 2025 — Wolters Kluwer Legal & Regulatory has today completed the previously...
-
SAN FRANCISCO, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Fundbox, the leading embedded capital infrastructure provider for small businesses, today announced a new partnership with Wave, the financial...
-
LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- CECOCECO, a leading innovator in the lighting and display industry, today announced the launch of ArtMorph Elite, along with its seamlessly compatible...
-
HAZELWOOD, Mo., Nov. 18, 2025 (GLOBE NEWSWIRE) -- ITF Group (“ITF”), a leading asset-backed 3PL provider of innovative logistics and supply chain solutions, has formally partnered with the...
-
LONDON and NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic...